The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions

Introduction: Prostate-specific antigen velocity (PSAV) is used to monitor men with clinical suspicion of prostate cancer (PCa), with a normal cut-off point of 0.3–0.5 ng/mL/year. The aim of the study is to establish the predictive capacity of PSAV (value and acceleration) and of the free PSA/total...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores-Fraile, María-Carmen, Padilla-Fernández, Bárbara Yolanda, Valverde-Martínez, Sebastián, Marquez-Sanchez, Magaly, García-Cenador, María-Begoña, Lorenzo-Gómez, María-Fernanda, Flores-Fraile, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690774/
https://www.ncbi.nlm.nih.gov/pubmed/33114134
http://dx.doi.org/10.3390/jcm9113400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690774/
https://www.ncbi.nlm.nih.gov/pubmed/33114134
http://dx.doi.org/10.3390/jcm9113400

Ejemplares similares